Anti‐Melanoma Differentiation‐Associated Gene 5 Antibody‐Positive Interstitial Lung Disease, Induced by Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Carcinoma
We report the first case of anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease induced by enfortumab vedotin plus pembrolizumab in a patient with advanced urothelial carcinoma.
Authors
- Akira Saitō (ORCID: https://orcid.org/0000-0003-4204-1487)
- Hanae Kondo
- Hiroki Ishihara
- Toshio Takagi
- Yasunobu Hashimoto
Institutions
- Tokyo Women's Medical University (JP)
- Noguchi Hospital (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1002/iju5.70148
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 24.20